Jeannette Daum
Acute Care · Seaford, DENPI 1548772577
Payments from drug & device makers
What this record shows
21 manufacturers reported payments, led by Medtronic at 51.1% of the total. Reporting peaked in 2024 at $2,788 and has fallen 98.1% since, to $53 in 2025. Among acute care clinicians in DE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 147 payments — averaging $41.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Abbott$776
- AstraZeneca$571
- Boehringer Ingelheim$468
- Philips North America LLC$211
- Sanofi$203
- plus $766 from 15 others
What the payments were for
- Travel & lodging$2,68544%
- Food & beverage$3,44356%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 30 | $3,133 |
| Abbott | 4 | $776 |
| AstraZeneca | 29 | $571 |
| Boehringer Ingelheim | 21 | $468 |
| Philips North America LLC | 17 | $211 |
| Sanofi | 10 | $203 |
| Mylan Specialty L.p. | 8 | $149 |
| GSK | 4 | $84 |
| Edwards Lifesciences | 1 | $72 |
| Mallinckrodt Hospital Products Inc. | 3 | $71 |
| Regeneron Healthcare Solutions, Inc. | 4 | $70 |
| United Therapeutics Corporation | 3 | $56 |
| Actelion Pharmaceuticals US, Inc. | 2 | $46 |
| Bayer | 2 | $43 |
| Johnson & Johnson | 1 | $38 |
| Jazz Pharmaceuticals Inc. | 2 | $35 |
| Gilead | 2 | $33 |
| Shionogi Inc | 1 | $21 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Pulmonx Corporation | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$1,745
- MitraClip$767
- TAGRISSO$110
How this compares
$6,129 in reported general payments places this provider in the 95th percentile of 26 acute care providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Potassium Chloride | 19 | $131 |
| Amoxicillin | 67 | $97 |
| Furosemide | 15 | $48 |
| Azithromycin | 16 | $45 |
Paid to pharmacies, not to this prescriber.
Other acute care in Seaford
- Pamela BlondinLewes$6K
- Rachel FieldsLewes$3K
- Shanna AmorosoNewark$2K
- Youngja MooreNewark$1K
- Andrew VincentWilmington$1K
- Matthew FranklinNewark$1K
- Karen RussellDover$861
- Thomas TrobianoLewes$787
- Lashay DavisWilmington$427
- Mary GrossRehoboth Beach$407
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.